Definitive Contract 75D30118C02863
- Not listed
- This is a federal delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Cayman Chemical Co Inc. for the provision of DLS Traceable Opioid Kits. The contract is a firm fixed-price award with a ceiling value of $499,800.00 and a period of performance through September 28, 2023. Cayman Chemical Co Inc. is a leading supplier of biochemical products and research tools, with a focus on supporting government agencies in areas such as drug enforcement, public...
- This federal contract award to Cayman Chemical Co Inc. is for the delivery of EMERGENT DRUG PANEL-VERSION 1 (EDP-V1) KITS to the Centers for Disease Control and Prevention (CDC) Pittsburgh location. The $996,622.60 firm fixed-price delivery order has a completion date of September 29, 2024. Cayman Chemical, a for-profit manufacturer of biochemical products and research tools, specializes in providing reference materials, analytical standards, and specialized reagents to support drug enforcement,...
- The U.S. Drug Enforcement Administration (DEA) awarded a $117,910.00 Firm Fixed Price purchase order to Cayman Chemical Co Inc., a for-profit manufacturer of biochemicals and research tools located in Ann Arbor, Michigan. The contract is for the procurement of 16 substances to support the DEA's drug enforcement activities, with a period of performance ending on April 29, 2025. Cayman Chemical has a history of securing federal contracts from agencies such as the Defense Health Agency, Centers for...
- This is a $24,069 firm-fixed-price purchase order awarded by the Drug Enforcement Administration (DEA) to Cayman Chemical Co Inc., a manufacturer of biochemical products and research tools. The contract supports the DEA's drug enforcement and analysis efforts by providing reference materials, analytical standards, and specialized reagents. Cayman Chemical has an established track record of supplying the DEA and other federal agencies, such as the Centers for Disease Control and Prevention...
- This is a firm fixed-price BPA call contract awarded by the Defense Health Agency to Cayman Chemical Co Inc., a for-profit manufacturer of biochemical products and research tools located in Ann Arbor, Michigan. The contract, valued at $11,273.16, is for drug screening and confirmation testing of suspected drug use in service member investigative and/or post-mortem urine, blood, and tissue samples. The contract has a period of performance through September 30, 2025 and is not set aside for...
- The Department of Justice Drug Enforcement Administration awarded a $30,300 firm fixed price purchase order to Cayman Chemical Co Inc. to process an order for six controlled substances through January 2025. The award stems from a January 2024 special notice requesting synthetic substances for pharmacological testing to support the Drug and Chemical Evaluation Section's work in gathering information on drugs of concern and potentially schedule substances not currently controlled. Cayman...
- This is a firm fixed-price purchase order awarded by the Drug Enforcement Administration (DEA) to Cayman Chemical Co Inc. for $84,575.00. The contract is for the purchase of 17 substances for diversion and control purposes. Cayman Chemical Co Inc. is a leading supplier of biochemical products and research tools to federal agencies, specializing in the production of high-quality chemicals, assay kits, antibodies, and recombinant proteins. The contract has a total small business set-aside...
- This is a $27,350.00 firm fixed price purchase order awarded to Cayman Chemical Co Inc. by the Drug Enforcement Administration (DEA) on August 1, 2024. The contract is for the purchase of three substances to be used in testing, with a delivery date of December 20, 2024. Cayman Chemical Co Inc. is a leading supplier of biochemical products and research tools to federal agencies, specializing in the production of high-quality chemicals, assay kits, antibodies, and recombinant proteins. The company...
- This is a firm-fixed price BPA call order awarded by the Defense Health Agency (DHA) to Cayman Chemical Co Inc., a leading manufacturer of biochemical products and research tools. The contract, valued at $11,540.48, is for the delivery of drug standards to be used for drug screening and evaluation testing of service member specimens. Cayman Chemical has an established track record of providing reference materials, analytical standards, and specialized reagents to support federal agencies' drug...
- This firm fixed-price purchase order was awarded by the Department of the Interior US Geological Survey Office of Acquisitions and Grants to Cayman Chemical Co Inc., a small business manufacturer of high-quality biochemicals, assay kits, antibodies, and recombinant proteins. The $21,294.72 contract is for the delivery of MICROCYSTIN-LR/CYLINDROSPERMOPSIN and has an October 16, 2015 completion date. Cayman Chemical is known for providing specialized reagents, test kits, medical supplies,...
The U.S. Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $1,330,000.00 firm fixed price definitive contract to Cayman Chemical Co Inc., a for-profit manufacturer of biochemicals, assay kits, and medical supplies located in Ann Arbor, Michigan. The contract is for the delivery of opioid detection kits to support the CDC's public health initiatives related to the opioid epidemic. Cayman Chemical has also provided controlled substance standards to the Drug Enforcement Agency and the U.S. Army, as well as research materials to the National Institutes of Health. The company holds several active indefinite delivery contract vehicles, including a $1.5 million blanket purchase agreement with the Defense Health Agency for chemicals and medical supplies, and a $130,000 blanket purchase agreement with the Department of the Army Medical Command for chemicals used in forensic drug testing. Additionally, Cayman Chemical is part of a multiple award $23.65 million indefinite delivery contract with the CDC to provide serology testing in support of the COVID-19 response. This contract award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | $250.0k | 1/15/19 | |
| Not listed | Not listed | $1.1m | 9/11/18 |